Drug recall · May 3, 2023
Pantoprazole sodium for Injection 40 mg*/vial recall
Why: CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous Infusion Only, Mfd. for Methapharm, Inc. Coral Springs, FL, 33065, NDC 67850-150-10 (carton), NDC 67850-150-00 (vial).
- Lots / codes
Lots: 220801; 220802; 220803 Exp. July 2024
- Quantity
- 5377 cartons
- Company
- Methapharm Inc, Coral Springs, FL
- Distribution
- Nationwide in the USA
- Initiated
- April 7, 2023 · Voluntary: Firm initiated
- Classified
- April 21, 2023
- Reported
- May 3, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pantoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.